Relationship of autonomic imbalance and circadian disruption with obesity and type 2 diabetes in resistant hypertensive patients

被引:47
作者
Boer-Martins, Leandro [1 ,4 ]
Figueiredo, Valeria N. [1 ]
Demacq, Caroline [1 ,4 ]
Martins, Luiz C. [1 ]
Consolin-Colombo, Fernanda [3 ]
Figueiredo, Marcio J. [2 ]
Cannavan, Fernando P. S. [2 ]
Moreno, Heitor, Jr. [1 ]
机构
[1] State Univ Campinas UNICAMP, Fac Med Sci & Clin Hosp, Cardiovasc Pharmacol Lab, Sao Paulo, Brazil
[2] State Univ Campinas UNICAMP, Fac Med Sci & Clin Hosp, Dept Cardiol, Sao Paulo, Brazil
[3] Univ Sao Paulo, Fac Med, Clin Hosp Sao Paulo, Hypertens Unit,Heart Inst InCor, Sao Paulo, Brazil
[4] Novartis Biociencias SA, Pharma Sector, Cardiovasc & Metab Unit, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
HEART-RATE-VARIABILITY; PROFESSIONAL-EDUCATION-COMMITTEE; BLOOD-PRESSURE; INSULIN-RESISTANCE; ATHEROSCLEROSIS RISK; SCIENTIFIC STATEMENT; INCREASED MORTALITY; GENE-EXPRESSION; ASSOCIATION; MELLITUS;
D O I
10.1186/1475-2840-10-24
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Hypertension, diabetes and obesity are not isolated findings, but a series of interacting interactive physiologic derangements. Taking into account genetic background and lifestyle behavior, AI (autonomic imbalance) could be a common root for RHTN (resistant hypertension) or RHTN plus type 2 diabetes (T2D) comorbidity development. Moreover, circadian disruption can lead to metabolic and vasomotor impairments such as obesity, insulin resistance and resistant hypertension. In order to better understand the triggered emergence of obesity and T2D comorbidity in resistant hypertension, we investigated the pattern of autonomic activity in the circadian rhythm in RHTN with and without type 2 diabetes (T2D), and its relationship with serum adiponectin concentration. Methods: Twenty five RHTN patients (15 non-T2D and 10 T2D, 15 males, 10 females; age range 34 to 70 years) were evaluated using the following parameters: BMI (body mass index), biochemical analysis, serum adiponectinemia, echocardiogram and ambulatory electrocardiograph heart rate variability (HRV) in time and frequency domains stratified into three periods: 24 hour, day time and night time. Results: Both groups demonstrated similar characteristics despite of the laboratory analysis concerning T2D like fasting glucose, HbA1c levels and hypertriglyceridemia. Both groups also revealed disruption of the circadian rhythm: inverted sympathetic and parasympathetic tones during day (parasympathetic > sympathetic tone) and night periods (sympathetic > parasympathetic tone). T2D group had increased BMI and serum triglyceride levels (mean 33.7 +/- 4.0 vs 26.6 +/- 3.7 kg/m(2) - p = 0.00; 254.8 +/- 226.4 vs 108.6 +/- 48.7 mg/dL - p = 0.04), lower levels of adiponectin (6729.7 +/- 3381.5 vs 10911.5 +/- 5554.0 ng/mL - p = 0.04) and greater autonomic imbalance evaluated by HRV parameters in time domain compared to non-T2D RHTN patients. Total patients had HRV correlated positively with serum adiponectin (r = 0.37 [95% CI - 0.04 - 1.00] p = 0.03), negatively with HbA1c levels (r = -0.58 [95% CI -1.00 - -0.3] p = 0.00) and also adiponectin correlated negatively with HbA1c levels (r = -0.40 [95% CI -1.00 - -0.07] p = 0.02). Conclusion: Type 2 diabetes comorbidity is associated with greater autonomic imbalance, lower adiponectin levels and greater BMI in RHTN patients. Similar circadian disruption was also found in both groups indicating the importance of lifestyle behavior in the genesis of RHTN.
引用
收藏
页数:12
相关论文
共 55 条
[1]   Adiponectin: from obesity to cardiovascular disease [J].
Antoniades, C. ;
Antonopoulos, A. S. ;
Tousoulis, D. ;
Stefanadis, C. .
OBESITY REVIEWS, 2009, 10 (03) :269-279
[2]   Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension - A randomized controlled trial [J].
Bakris, GL ;
Fonseca, V ;
Katholi, RE ;
McGill, JB ;
Messerli, FH ;
Phillips, RA ;
Raskin, P ;
Wright, JT ;
Oakes, R ;
Lukas, MA ;
Anderson, KM ;
Bell, DSH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (18) :2227-2236
[3]   Resistant hypertension: Diagnosis, evaluation, and treatment - A Scientific Statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research [J].
Calhoun, David A. ;
Jones, Daniel ;
Textor, Stephen ;
Goff, David C. ;
Murphy, Timothy P. ;
Toto, Robert D. ;
White, Anthony ;
Cushman, William C. ;
White, William ;
Sica, Domenic ;
Ferdinand, Keith ;
Giles, Thomas D. ;
Falkner, Bonita ;
Carey, Robert M. .
HYPERTENSION, 2008, 51 (06) :1403-1419
[4]  
Camm AJ, 1996, CIRCULATION, V93, P1043
[5]   Risk factors for progression to incident hyperinsulinemia: The Atherosclerosis Risk in Communities Study, 1987-1998 [J].
Carnethon, MR ;
Fortmann, SP ;
Palaniappan, L ;
Duncan, BB ;
Schmidt, MI ;
Chambless, LE .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 158 (11) :1058-1067
[6]   Intensive Monitoring of Adherence to Treatment Helps to Identify "True" Resistant Hypertension [J].
de Souza, Walneia Aparecida ;
Sabha, Maricene ;
Favero, Fabricio de Faveri ;
Bergsten-Mendes, Gun ;
Yugar-Toledo, Juan Carlos ;
Moreno, Heitor, Jr. .
JOURNAL OF CLINICAL HYPERTENSION, 2009, 11 (04) :183-191
[7]   Characteristics and Predictors of Obstructive Sleep Apnea in Patients With Systemic Hypertension [J].
Drager, Luciano F. ;
Genta, Pedro R. ;
Pedrosa, Rodrigo P. ;
Nerbass, Flavia B. ;
Gonzaga, Carolina C. ;
Krieger, Eduardo M. ;
Lorenzi-Filho, Geraldo .
AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (08) :1135-1139
[8]   Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty [J].
Ershler, WB ;
Keller, ET .
ANNUAL REVIEW OF MEDICINE, 2000, 51 :245-270
[9]   Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes [J].
Fasshauer, M ;
Kralisch, S ;
Klier, M ;
Lossner, U ;
Bluher, M ;
Klein, J ;
Paschke, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 301 (04) :1045-1050
[10]   Relationship between autonomic dysfunction, insulin resistance and hypertension, in diabetes [J].
Frontoni, S ;
Bracaglia, D ;
Gigli, F .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2005, 15 (06) :441-449